Enzymatic method for the synthesis of blockbuster drug intermediates - Synthesis of five-membered cyclic γ-amino acid and γ-lactam enantiomers

European Journal of Organic Chemistry

Volumn , Issue 31, 2008, Pages 5263-5268

  Forró, Eniko ^a   Fülöp, Ferenc ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Amino acids; Enzyme catalysis; Lactams

Indexed keywords

EID: 55049084118     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.200800723     Document Type: Article

References (40)

1. R. D. Allan, H. W. Dickenson, J. Fong, Eur. J. Pharmacol. 1986, 122, 339-348;
2. D. L. Crittenden, A. Park, J. Qiu, R. B. Silverman, R. K. Duke, G. A. R. Johnston, M. J. T. Jordan, M. Chebib, Bioorg. Med. Chem. 2006, 14, 447-455.
3. M. Ordonez, C. Cativiela, Tetrahedron: Asymmetry 2007, 18, 3-99.
4. a) J. Weiss, N. Weis, N. Ketabi-Kiyanvash, C. H. Storch, G. Caroline, W. E. Haefeli, Eur. J. Pharmacol. 2008, 579, 104-109;
5. b) S. Ramanathan, G. Shen, J. Hinkle, J. Enejosa, B. P. Kearney, J. Acquir. Immune Defic. Syndr. 2007, 46, 160-166;
6. c) L. J. Waters, G. Moyle, S. Bonora, A. D'Avolio, L. Else, S. Mandalia, A. Pozniak, M. Nelson, B. Gazzard, D. Back, M. Boffito, Antivir. Ther. 2007, 12, 825-830;
7. d) M. A. Wainberg, J. L. Martinez-Cajas, B. G. Brenner, Fut. HIV Ther. 2007, 1, 291-313;
8. e) A. Kleemann, J. Engel, B. Kutschher, D. Reichert, Pharmaceutical Substances, Thieme, Stuttgart, 2001, pp. 1-4.
9. a) N. Venhoff, B. Setzer, K. Melkaoui, U. A. Walker, Antivir. Ther. 2007, 12, 1075-1085;
10. b) B. G. Roy, P. K. Jana, B. Achari, S. B. Mandal, Tetrahedron Lett. 2007, 48, 1563-1566;
11. c) M. Freiria, A. J. Whitehead, W. B. Motherwell, Synthesis 2005, 18, 3079-3084.
12. a) J. Melroy, V. Nair, Curr. Pharm. Des. 2005, 11, 3847-3852;
13. b) P. K. Sharma, V. Nair, Recent Res. Developments Org. Chem. 2000, 4, 53-86;
14. c) S. M. Roberts, N. M. Williamson, Curr. Org. Chem. 1997, 1, 1-20;
15. d) P. S. Hervey, C. M. Perry, Drugs 2000, 60, 447-479;
16. e) J. Melroy, V. Nair, Curr. Pharm. Des. 2005, 11, 3847-3852;
17. f) P. S. Hervey, C. M. Perry, Drugs 2000, 60, 447-479.
18. S. M. Daluge, M. T. Martin, B. R. Sickles, D. A. Livingston, Nucleos. Nucleot. Nucl. 2000, 19, 297-327.
19. a) M. T. Crimmins, Tetrahedron 1998, 54, 9229-9272;
20. b) M. Ferrero, V. Gotor, Chem. Rev. 2000, 100, 4319-4347.
21. D. E. Levy, M. Bao, D. B. Cherbavaz, J. E. Tominson, D. M. Sedlock, C. J. Homcy, R. M. Scarborough, J. Med. Chem. 2003, 46, 2177-2186.
22. C. Evans, R. McCague, S. M. Roberts, A. G. Sutherland, J. Chem. Soc. Perkin Trans. 1 1991, 656-657.
23. H. Nohira, K. Hara, K. Nagashima, T. Hayashibara, Eur. Pat. Appl., EP 590685 A1, 1994, 9 pp.
24. R. Csuk, P. Dörr, Tetrahedron: Asymmetry 1994, 5, 269-276.
25. C. T. Evans, S. M. Roberts, M. Stanley, Eur. Pat. Appl. EP 424064 A17, 1991, 7 pp..
26. S. J. C. Taylor, R. McCague, R. Wisdom, C. Lee, K. Dickson, G. Ruesroft, F. O'Brien, J. Littlechild, J. Bevan, S. M. Roberts, C. T. Evans, Tetrahedron: Asymmetry 1993, 4, 1117-1128.
27. S. Daluge, R. V. Robert, J. Org. Chem. 1978, 43, 2311-2320;
28. M. L. Peterson, V. Robert, J. Med. Chem. 1990, 33, 1214-1219.
29. E. Forró, J. Árva, F. Fülöp, Tetrahedron: Asymmetry 2001, 12, 643-649.
30. J. A. Campbell, W. K. Lee, H. Rapoport, J. Org. Chem. 1995, 60, 4602-4616.
31. a) E. Forró, F. Fülöp, Org. Lett. 2003, 5, 1209-1212;
32. b) E. Forró, F. Fülöp, Chem. Eur. J. 2006, 12, 2587-2592.
33. E. Forró, F. Fülöp, Chem. Eur. J. 2007, 13, 6397-6401.
34. E. Forró, F. Fülöp, Tetrahedron: Asymmetry 2008, 19, 1005-1009.
35. R. Vaidyanathan, L. Hesmondhalgh, S. Hu, Org. Process Res. Dev. 2007, 11, 903-906.
36. a) F. Arndt, Org. Synth. 1943, 2, 165;
37. b) J. A. More, D. E. Reed, Org. Synth. 1973, 5, 351.
38. M. J. Milewska, T. Poloński, Tetrahedron: Asymmetry 1994, 5, 359-362.
39. K. Tanaka, M. Kato, F. Toda, Heterocycles 2001, 54, 405-410.
40. S. J. C. Taylor, R. McCague, R. Wisdom, C. Lee, K. Dickson, G. Ruecroft, F. O'Brien, J. Littlechild, J. Bevan, S. M. Roberts, C. T. Evans, Tetrahedron: Asymmetry 1993, 4, 1117-1128.